Oramed's New Joint Venture Aims to Revolutionize Oral Insulin Development Oramed Pharmaceuticals has launched a new venture, OraTech Pharmaceuticals, to innovate oral insulin delivery. This strategic collaboration should enhance diabetes treatment globally.

Oramed's New Joint Venture Aims to Revolutionize Oral Insulin Development #United_States #New_York #OraTech #Oramed #HTIT